KDDI Uses Wind River Studio for Its Commercial Deployment of 5G Open vRAN Sites in Japan

ALAMEDA, Calif.--(BUSINESS WIRE)--#5g--Wind River®, a global leader in delivering software for mission-critical intelligent systems, today…

KDDI Uses Wind River Studio for Its Commercial Deployment of 5G Open vRAN Sites in Japan

ALAMEDA, Calif.--(BUSINESS WIRE)--#5g--Wind River®, a global leader in delivering software for mission-critical intelligent systems, today…

Melco garners 97 Stars in 2023 Forbes Travel Guide – maintaining lead among Macau and Asia’s integrated resorts

MACAU - Media OutReach - 15 February 2023 - Melco Resorts & Entertainment has been…

NaturalShrimp Collaborates with Australian Companies in a Prawn Farm Wastewater Trial

DALLAS--(BUSINESS WIRE)--NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the…

NaturalShrimp Collaborates with Australian Companies in a Prawn Farm Wastewater Trial

DALLAS--(BUSINESS WIRE)--NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the…

NaturalShrimp Collaborates with Australian Companies in a Prawn Farm Wastewater Trial

DALLAS--(BUSINESS WIRE)--NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the…

TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)

Patients underwent BNCT using TAE Life Sciences’ Neutron Beam System as part of Neuboron Medical…

TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)

Patients underwent BNCT using TAE Life Sciences’ Neutron Beam System as part of Neuboron Medical…

TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)

Patients underwent BNCT using TAE Life Sciences’ Neutron Beam System as part of Neuboron Medical…

Anteris Announces Completion of A$35 Million Capital Raise and Provides 2023 Goalposts

Company Funded Through Results of U.S. Early Feasibility Study of DurAVR™ BRISBANE, Australia and EAGAN,…